CT
ABBV icon

Colonial Trust’s AbbVie ABBV Stock Holding History

Colonial Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
7,817
-1,749
-18% -$376K 0.25% 97
2026
Q1 		$2.08M Sell
9,566
-98
-1% -$21.7K 0.28% 88
2025
Q4 		$2.21M Buy
9,664
+359
+4% +$81.8K 0.29% 83
2025
Q3 		$2.15M Sell
9,305
-196
-2% -$39.9K 0.29% 84
2025
Q2 		$1.76M Buy
9,501
+103
+1% +$19.1K 0.26% 90
2025
Q1 		$1.97M Buy
9,398
+12
+0.1% +$2.33K 0.31% 81
2024
Q4 		$1.67M Sell
9,386
-2,701
-22% -$497K 0.25% 89
2024
Q3 		$2.39M Buy
12,087
+2,695
+29% +$503K 0.37% 72
2024
Q2 		$1.61M Buy
9,392
+475
+5% +$78.7K 0.28% 82
2024
Q1 		$1.62M Sell
8,917
-52
-0.6% -$8.96K 0.3% 80
2023
Q4 		$1.39M Buy
8,969
+272
+3% +$39.7K 0.29% 84
2023
Q3 		$1.3M Buy
8,697
+78
+0.9% +$11.5K 0.32% 75
2023
Q2 		$1.16M Buy
8,619
+400
+5% +$58.7K 0.28% 82
2023
Q1 		$1.31M Buy
8,219
+1,127
+16% +$172K 0.33% 77
2022
Q4 		$1.15M Buy
7,092
+244
+4% +$37.4K 0.31% 78
2022
Q3 		$919K Buy
+6,848
New +$983K 0.29% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Colonial Trust's ABBV Position: Q2 2026 in Review

Colonial Trust reduced its AbbVie (ABBV) stake by 18% in Q2 2026, selling an estimated $376K and leaving 7,817 shares worth $1.97M. The position accounts for 0.25% of the portfolio, ranked #97.

Colonial Trust first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.39M in Q3 2024. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Colonial Trust held 7,817 shares of AbbVie worth $1.97M as of Q2 2026.
  • Colonial Trust sold 1,749 AbbVie shares in Q2 2026, an estimated $376K.
  • AbbVie made up 0.25% of Colonial Trust's portfolio in Q2 2026, its #97 holding.
  • Colonial Trust first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • Colonial Trust's AbbVie position peaked at $2.39M in Q3 2024.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.